SAAS, Andorra  

COVonco

Rejoignez l’étude COVonco et contribuez a comprendre mieux l’impact de la COVID-19 dans l’oncologie.

France  

EpiCOV

Le projet EpiCOV vise à fournir une cartographie globale et scientifiquement fiable du statut immunitaire de la population en France à travers des tests sérologiques et des questionnaires.

Catalunya Central Health region, Spain  

COnV-ert study, convalescent plasma to stop COVID-19

Early administration of convalescent plasma in people over 50 years of age with mild to moderate COVID-19 disease may slow disease progression and decrease the severity of symptoms.

Institut Català de la Salut, Spain  

COVID-19 immunity in healthcare professionals

Determining whether there is protection against reinfection is important for controlling healthcare workers implications during the pandemic due to their continous professional contact with COVID-19 patients

Technische Universität München, Germany  

CoViproteHCt

Identifying true markers of protective immunity will allow for the identification of individuals, in particular healthcare personnel working with COVID-19 patients and in other critical areas protected from re-infection.

Catalonia, Spain  

COVICAT Study

The COVICAT study aims to evaluate the evolution of the incidence of SARS-CoV-2 coronavirus infection in the Catalan population over a 12-month period.

Assistance Publique des Hopitaux de Paris, France  

Convalescent plasma therapy and COVID-19

Convalescent plasma with anti-SARS-CoV-2 antibodies appears to be a very promising approach in the context of protracted COVID-19 symptoms in patients unable to mount a specific humoral response to SARS-CoV-2.

Imperial College London et al., United Kingdom  

REACT-2.5: National seroprevalence study of SARS-CoV-2 antibodies using LFIAs

This cross-sectional study estimates SARS-CoV-2 IgG antibody seroprevalence in the community in England using self-administered LFIAs.

Imperial College London et al., United Kingdom  

REACT-2.4: Usability and validity of LFIA self-testing in key workers

This study assesses whether LFIAs should be used as a self-administered test among key workers or whether better performance is obtained if they attend a central clinic facility, e.g. for blood draw.

Imperial College London et al., United Kingdom  

REACT-2.3: Acceptability and Usability of In-home Self-testing for SARS-CoV-2

This COVID-19 study aims to evaluate the acceptability and usability of in-home self-testing for SARS-CoV-2 antibodies.

Imperial College London et al., United Kingdom  

REACT-2.2: Feasibility of COVID-19 Self-testing

Which are the issues of self-testing? This study aims to assess the feasibility of finger-prick antibody testing at home to prove the design of the larger-scale COVID-19 studies.

Imperial College London et al., United Kingdom  

REACT-2.1: Evaluation of SARS-CoV-2 lateral flow immunoassays

How accurate are lateral flow immunoassays? This epidemiological study compares LFIAs with other COVID-19 tests.